King of Prussia, PA, United States of America

Yu Xue


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yu Xue

Introduction

Yu Xue, an accomplished inventor based in King of Prussia, Pennsylvania, has made significant strides in the field of biotechnology. With a total of three patents to his name, Xue has focused his efforts on developing antigen binding proteins that target critical receptors in humans, particularly those associated with various diseases and cancers.

Latest Patents

Among Yu Xue's notable patents are innovations related to CD127 binding proteins. These antigen binding proteins specifically bind to the human IL-7 receptor (CD127) and are primarily useful in the treatment of autoimmune diseases, including multiple sclerosis. Furthermore, he has developed additional antigen binding proteins that target HER3. This innovation includes polynucleotides encoding such proteins and pharmaceutical compositions that utilize these antibodies. Notably, these advancements hold promise in the treatment or prophylaxis of numerous cancers such as breast, ovarian, prostate, bladder, pancreatic, gastric, melanoma, and other cancers that overexpress the HER3 receptor.

Career Highlights

Xue has a distinguished career, having worked with leading companies in the pharmaceutical industry, including Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. His work in these organizations has significantly contributed to the advancement of medical therapies and innovations in the market.

Collaborations

Throughout his career, Yu Xue has collaborated with esteemed colleagues such as Ian Kirby and Thomas Matthew Webb. These partnerships have been instrumental in fostering innovation and pushing the boundaries of current research.

Conclusion

Yu Xue's contributions to the field of biotechnology through his patents and collaborations demonstrate his commitment to addressing critical health challenges. His work not only advances scientific knowledge but also offers potential therapeutic solutions for patients suffering from autoimmune diseases and various forms of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…